C REACTIVE PROTEIN IN PATIENTS WITH CHRONIC RENAL DISEASES

Autor: Luca Giovannini, Vincenzo Panichi, M. Norpoth, Maria Rita Metelli, Roberto Palla, D Taccola, S De Pietro, Massimiliano Migliori, A. M. Bianchi, C. Tetta
Rok vydání: 2001
Předmět:
Zdroj: Renal Failure. 23:551-562
ISSN: 1525-6049
0886-022X
DOI: 10.1081/jdi-100104737
Popis: Base-line serum levels of plasma C-reactive protein (CRP) are predictive of future myocardial infarction and sudden cardiac death in apparently healthy subjects, suggesting the hypothesis that chronic inflammation might be important in the pathogenesis of atherothrombosis. CRP production is mediated by several inflammatory mediators: interleukin 6 (IL-6) is currently felt to be the major cytokine influencing the acute phase response. CRP and other acute phase proteins are elevated in dialysis patients and cardiovascular diseases represent the single largest cause of mortality in chronic renal failure patients. Little information is available, however regarding CRP and IL-6 plasma levels in pre-dialysis renal failure. Plasma CRP was determined by a modification of the laser nephelometry technique; IL-6 by immunoassay (RD System); and fibrinogen, serum albumin, cholesterol, triglycerides, hematocrit, white blood cell count, erythrocytic sedimentation rate (ESR) and urinary protein levels by standard laboratory techniques. Results were obtained in 102 chronic pre-dialysis patients whose mean age was 53+/-5.8 years with a mean creatinine clearance (C(Cr)) of 52+/-37 mL/min). CRP was greater than 5 mg/L in 25% of the global population. CRP and IL-6 were 4.0+/-4.6 mg/L and 5.8+/-5.6 pg/mL, respectively and were not significantly correlated (r=0.11, p=n.s.). CRP and IL-6 were however related with renal function (CRP versus C(Cr) r=-0.40 p
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje